18411431

Source:http://linkedlifedata.com/resource/pubmed/id/18411431

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0144576, umls-concept:C0278488, umls-concept:C0796392
pubmed:issue	15
pubmed:dateCreated	2008-4-14
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18411431-18160686
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1533-4406
pubmed:author	pubmed-author:GridelliCesareC, pubmed-author:RossiAntonioA, pubmed-author:TorriValterV
pubmed:issnType	Electronic
pubmed:day	10
pubmed:volume	358
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1637; author reply 1637-8
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:18411431-Antibodies, Monoclonal, pubmed-meshheading:18411431-Antibodies, Monoclonal, Humanized, pubmed-meshheading:18411431-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18411431-Bias (Epidemiology), pubmed-meshheading:18411431-Breast Neoplasms, pubmed-meshheading:18411431-Disease Progression, pubmed-meshheading:18411431-Humans, pubmed-meshheading:18411431-Paclitaxel, pubmed-meshheading:18411431-Research Design
pubmed:year	2008
pubmed:articleTitle	Paclitaxel plus bevacizumab for metastatic breast cancer.
pubmed:publicationType	Letter, Comment